Competition of thermodynamic and dynamic factors during formation of multicomponent particles via spray drying

Journal of Pharmaceutical Sciences

Volumn 102, Issue 2, 2013, Pages 518-529

  Kawakami, Kohsaku ^a   Hasegawa, Yusuke ^a,b   Deguchi, Kenzo ^a   Ohki, Shinobu ^a   Shimizu, Tadashi ^a   Yoshihashi, Yasuo ^b   Yonemochi, Etsuo ^b   Terada, Katsuhide ^b  

^a NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Amorphous; Hygroscopicity; Miscibility; Psicose; Solid state NMR; Spray drying; Thermal analysis

Indexed keywords

ASPARTAME; DEXTRIN; HYDROXYPROPYLMETHYLCELLULOSE; POVIDONE; PSICOSE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION COEFFICIENT; FREEZE DRYING; GLASS TRANSITION TEMPERATURE; HYDROPHILICITY; MATHEMATICAL MODEL; MELTING POINT; MISCIBILITY; MOLECULAR WEIGHT; PARTICLE SIZE; PHASE SEPARATION; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TEMPERATURE SENSITIVITY; THERMODYNAMICS;

EID: 84872500156     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23378     Document Type: Article

References (23)

1. Kawakami K. 2012. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev 64:480-495.
2. Vehring R. 2008. Pharmaceutical particle engineering via spray drying. Pharm Res 25:999-1022.
3. Kawakami K, Sumitani C, Yoshihashi Y, Yonemochi E, Terada K. 2010. Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles. Int J Pharm 390:250-259.
4. Kawakami K. 2012. Miscibility analysis of particulate solid dispersions prepared by electrospray deposition. Int J Pharm 433:71-78.
5. Merisko-Liversidge E, Liversidge GG. 2011. Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev 63:427-440.
6. Sou T, Meeusen EN, de Veer M, Morton DAV, Kaminskas LM, McIntosh MP. 2011. New developments in dry powder pulmonary vaccine delivery. Trends Biotechnol 29:191-198.
7. Zhang J, Wu L, Chan HK, Watanabe W. 2011. Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Deliv Rev 63:441-455.
8. D'Addioa SM, Prud'homme RK. 2011. Controlling drug nanoparticle formation by rapid precipitation. Adv Drug Deliv Rev 63:417-426.
9. Yasuji T, Takeuchi H, Kawashima Y. 2008. Particle design of poorly water-soluble drug substances using supercritical fluid technologies. Adv Drug Deliv Rev 60:388-398.
10. Okamoto H, Danjo K. 2008. Application of supercritical fluid to preparation of powders of high-molecular weight drugs for inhalation. Adv. Drug Deliv Rev 60:433-446.
11. Chakraborty S, Liao IC, Adler A, Leong KW. 2009. Electrohydrodynamics: A facile technique to fabricate drug delivery systems. Adv Drug Deliv Rev 61:1043-1054.
12. Zhang S, Kawakami K, Yamamoto M, Masaoka Y, Kataoka M, Yamashita S, Sakuma S. 2011. Coaxial electrospray formulations for improving oral absorption of a poorly water-soluble drug. Mol Pharm 8:807-813.
13. Matsuo T, Suzuki H, Hashiguchi M, Izumori K. 2002. D-Psicose is a rare sugar that provides no energy to growing rats. J Nutr Sci Vitaminol 48:77-80.
14. Hossain MA, Kitagaki S, Nakano D, Nishiyama A, Funamoto Y, Matsunaga T, Tsukamoto I, Yamaguchi F, Kamitori K, Dong Y, Hirata Y, Murao K, Toyoda Y, Tokuda M. 2011. Rare sugar d-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biochem Biophys Res Commun 405:7-12.
15. Sun Y, Hayakawa S, Ogawa M, Izumori K. 2007. Antioxidant properties of custard pudding dessert containing rare hexose, d-psicose. Food Control 18:220-227.
16. Takata MK, Yamaguchi F, Nakanose K, Watanabe Y, Hatano N, Tsukamoto I, Nagata M, Izumori K, Tokuda M. 2005. Neuroprotective effect of d-psicose on 6-hydroxydopamine-induced apoptosis in rat pheochromocytoma (PC12) cells. J Biosci Bioeng 100:511-516.
17. Hancock BC, Zografi G. 1994. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm Res 11:471-477.
18. Marsac PJ, Shamblin SL, Taylor LS. 2006. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 23:2417-2426.
19. Marsac PJ, Li T, Taylor LS. 2009. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res 26:139-151.
20. Kim JY, Noh ST, Bae YC. 1998. Phase behaviours of solid polymer electrolytes: Applicability of the melting point depression. Polymer 39:3473-3477.
21. 13C nuclear magnetic resonance spectroscopy. J Chem Phys 94:3200-3206.
22. Asano A, Takegoshi K, Hikichi K. 1992. Solid-state NMR study of miscibility and phase-separation of polymer blend: Polycarbonate/poly(methyl methacrylate). Polym J 24:555-562.
23. Jung SY, Yoshida H. 2006. Nano-scale structure change of amphiphilic di-block copolymer by blend. J Therm Anal Calorim 85:719-724.